Marshall Wace’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-198,900
Closed -$64.3M – 3090
2025
Q3
$64.3M Buy
+198,900
New +$61.9M 0.07% 261

Other funds holding ELV

Marshall Wace's ELV Position: Q3 2026 in Review

Marshall Wace increased its Elevance Health (ELV) stake by 1,332% in Q3 2026, buying an estimated $112M and bringing the position to 300,891 shares worth $117M. The position accounts for 0.1% of the portfolio, ranked #162.

Marshall Wace first reported a position in ELV in Q1 2014 and has held it in 35 quarters since. The position peaked at $251M in Q1 2023. 1,626 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Marshall Wace held 300,891 shares of Elevance Health worth $117M as of Q3 2026.
  • Marshall Wace bought 279,875 Elevance Health shares in Q3 2026, an estimated $112M.
  • Elevance Health made up 0.1% of Marshall Wace's portfolio in Q3 2026, its #162 holding.
  • Marshall Wace first reported a position in Elevance Health in Q1 2014 and has held it in 35 quarters since.
  • Marshall Wace's Elevance Health position peaked at $251M in Q1 2023.
  • 1,626 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.